WASHINGTON — As the COVID-19 pandemic continues and scientists predict more periods of social distancing and quarantine in the future, healthcare leaders in the VA and elsewhere are beginning to prepare for how this will impact the mental health of veterans and civilians alike.
WORCESTER, MA—While depression screening is recommended for all pregnant veterans, it had remained unknown how often symptomatic women received care, how depression treatment presented in practice, and whether women veterans were utilizing treatment during the...
WASHINGTON—While the VA has declared preventing veteran suicide to be their top priority, veterans continue to attempt or commit suicide at VA healthcare facilities. Recent reports from the VA Inspector General’s Office suggest that the deficiencies that allow these...
WASHINGTON — As leaders from across multiple federal agencies begin work on a roadmap to combat veteran suicide, they are searching for ways to turn existing efforts in towns, cities, counties and neighborhoods across the country into a net that can help catch struggling veterans.
PHILADELPHIA—Is esketamine a revolutionary treatment for depression or just another moderately effective adjunctive medication with some potentially serious risks? The VA’s Medical Advisory Panel leaned toward the latter position when it decided in June to approve the use of esketamine on a nonformulary basis for individuals who have previously failed at least two trials of other antidepressants.
Condition Significantly Increases Veterans’ Healthcare Costs ORLANDO, FL—VA clinicians now will be able to prescribe a form of ketamine to help patients with treatment-resistant depression. The condition is associated with healthcare resource utilization and costs at...
In 2008, the U.S. Food and Drug Administration issued an alert about increased risk for suicidal ideation and behavior for patients taking anti-epileptic drugs (AEDs).
